Webinar: State Strategies to Build Vaccine Confidence
This webinar explored state strategies to improve COVID-19 vaccine confidence and reach more communities in an equitable and efficient manner.
As of May 2021, all individuals ages 12 and older are eligible for COVID-19 immunizations. As states continue to design and roll out targeted vaccination campaigns, they are considering:
- The reasons why individuals are hesitant to get the COVID-19 vaccine;
- Current efforts to undermine confidence in the vaccine; and
- Solutions to address vaccine hesitancy.
Speakers from the US Centers for Disease Control and Prevention, the Oregon Health Authority, and AM TRACE discussed various types of vaccine hesitancy, practical issues around vaccination, emerging issues of misinformation, and places where interventions can improve vaccine confidence in order to support pandemic recovery.
Participants included:
- Moderator: Trish Riley, NASHP Executive Director
- Richard Quartarone, Communication Co-Deputy, Centers for Disease Control and Prevention
- Douglas Raymond Lyon, MD, Senior Health Advisor, Oregon Health Authority
- Jens Dakin, Managing Director, Information Operations/Strategic Communications, AM TRACE
This webinar is sponsored by AM TRACE with content development at the sole discretion of NASHP.



For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 























































































































































